Barclays’s Cassava Sciences SAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5K Sell
2,734
-41,396
-94% -$75.7K ﹤0.01% 4215
2025
Q1
$66K Sell
44,130
-49,449
-53% -$74K ﹤0.01% 3817
2024
Q4
$221K Buy
93,579
+18,832
+25% +$44.5K ﹤0.01% 3467
2024
Q3
$2.2M Buy
74,747
+53,487
+252% +$1.57M ﹤0.01% 2112
2024
Q2
$264K Sell
21,260
-30,098
-59% -$374K ﹤0.01% 2892
2024
Q1
$1.04M Sell
51,358
-54,232
-51% -$1.1M ﹤0.01% 2380
2023
Q4
$2.38M Buy
105,590
+78,888
+295% +$1.78M ﹤0.01% 2040
2023
Q3
$445K Buy
26,702
+6,711
+34% +$112K ﹤0.01% 2611
2023
Q2
$489K Sell
19,991
-12,510
-38% -$306K ﹤0.01% 2611
2023
Q1
$783K Sell
32,501
-11,155
-26% -$269K ﹤0.01% 2308
2022
Q4
$1.29M Buy
43,656
+22,114
+103% +$653K ﹤0.01% 1936
2022
Q3
$901K Buy
21,542
+902
+4% +$37.7K ﹤0.01% 2211
2022
Q2
$581K Sell
20,640
-3,621
-15% -$102K ﹤0.01% 2473
2022
Q1
$901K Sell
24,261
-86,747
-78% -$3.22M ﹤0.01% 2396
2021
Q4
$4.85M Buy
111,008
+54,207
+95% +$2.37M ﹤0.01% 1255
2021
Q3
$3.53M Buy
56,801
+51,960
+1,073% +$3.22M ﹤0.01% 1456
2021
Q2
$414K Sell
4,841
-22,491
-82% -$1.92M ﹤0.01% 2571
2021
Q1
$1.23M Buy
27,332
+16,718
+158% +$751K ﹤0.01% 2189
2020
Q4
$72K Sell
10,614
-66
-0.6% -$448 ﹤0.01% 3070
2020
Q3
$122K Sell
10,680
-18,602
-64% -$212K ﹤0.01% 2960
2020
Q2
$91K Buy
+29,282
New +$91K ﹤0.01% 3161
2013
Q4
Sell
-135
Closed -$2K 4404
2013
Q3
$2K Sell
135
-7,610
-98% -$113K ﹤0.01% 3978
2013
Q2
$120K Buy
+7,745
New +$120K ﹤0.01% 2945